- Home
- RNAC vs HRTX Comparison
RNAC vs HRTX Comparison
Compare RNAC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- HRTX
- Stock Information
- Founded
- RNAC 2007
- HRTX 1983
- Country
- RNAC United States
- HRTX United States
- Employees
- RNAC N/A
- HRTX N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- RNAC Health Care
- HRTX Health Care
- Exchange
- RNAC Nasdaq
- HRTX Nasdaq
- Market Cap
- RNAC 276.3M
- HRTX 276.1M
- IPO Year
- RNAC 2016
- HRTX 1987
- Fundamental
- Price
- RNAC $10.05
- HRTX $1.35
- Analyst Decision
- RNAC Strong Buy
- HRTX Strong Buy
- Analyst Count
- RNAC 4
- HRTX 2
- Target Price
- RNAC $40.00
- HRTX $4.50
- AVG Volume (30 Days)
- RNAC 48.4K
- HRTX 2.6M
- Earning Date
- RNAC 08-07-2025
- HRTX 08-08-2025
- Dividend Yield
- RNAC N/A
- HRTX N/A
- EPS Growth
- RNAC N/A
- HRTX N/A
- EPS
- RNAC N/A
- HRTX N/A
- Revenue
- RNAC $1,026,000.00
- HRTX $149,694,000.00
- Revenue This Year
- RNAC N/A
- HRTX $10.62
- Revenue Next Year
- RNAC N/A
- HRTX $12.99
- P/E Ratio
- RNAC N/A
- HRTX N/A
- Revenue Growth
- RNAC N/A
- HRTX 9.78
- 52 Week Low
- RNAC $8.46
- HRTX $1.04
- 52 Week High
- RNAC $26.50
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- RNAC 34.71
- HRTX 36.48
- Support Level
- RNAC $10.50
- HRTX $1.33
- Resistance Level
- RNAC $11.80
- HRTX $1.43
- Average True Range (ATR)
- RNAC 0.56
- HRTX 0.07
- MACD
- RNAC -0.11
- HRTX 0.02
- Stochastic Oscillator
- RNAC 0.45
- HRTX 45.45
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.